XERS Xeris Biopharma Holdings, Inc.

Fundamentals / CIK 0001867096 / USD

Xeris Biopharma Holdings, Inc. reported $368.3M in revenue and a net loss of $6.50M for the trailing twelve months ended September 30, 2026 (up 44.2% year over year), with a 87.4% gross margin and a 12.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open XERS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$300.6M$150.3M$0-$139.6MFY 2020 Revenue: $20.43MFY 2020 Net Income: -$91.14M2020FY 2021 Revenue: $49.59MFY 2021 Net Income: -$122.7M2021FY 2022 Revenue: $110.2MFY 2022 Net Income: -$94.66M2022FY 2023 Revenue: $163.9MFY 2023 Net Income: -$62.26M2023FY 2024 Revenue: $203.1MFY 2024 Net Income: -$54.84M2024FY 2025 Revenue: $291.8MFY 2025 Net Income: $554K2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $291.8M $203.1M $163.9M $110.2M $49.59M $20.43M
Cost of Revenue $42.57M $36.83M $28.64M $22.63M $13.32M $9.33M
Gross Profit $249.3M $166.2M $135.3M $87.61M $36.27M $11.11M
Research & Development $31.16M $25.56M $22.34M $20.97M $25.16M $20.92M
Selling, General & Admin $182.4M $163.5M $146.1M $137.7M $125.7M $73.73M
Operating Income $24.90M -$33.65M -$44.01M -$81.94M -$115.2M -$83.55M
EBITDA $26.21M -$32.42M -$42.52M -$80.54M -$113.8M -$82.08M
Interest Income $4.74M $5.32M $4.75M $2.58M $313K $2.96M
Interest Expense $29.08M $30.48M $26.61M $14.10M $7.18M $10.66M
Income Before Tax $554K -$57.10M -$63.50M -$96.08M -$122.7M --
Income Tax Expense $0 -$2.27M -$1.25M -$1.42M $0 -$110K
Net Income $554K -$54.84M -$62.26M -$94.66M -$122.7M -$91.14M
Basic EPS $0.00 -$0.37 -$0.45 -$0.70 -$1.55 -$2.14
Diluted EPS $0.00 -$0.37 -$0.45 -$0.70 -$1.55 -$2.14
Basic Shares Outstanding 160.4M 146.8M 137.7M 135.6M 79.0M 42.6M
Diluted Shares Outstanding 172.7M 146.8M 137.7M 135.6M 79.0M 42.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $107.2M $92.10M $83.13M $85.81M $74.38M $71.54M $60.12M $60.10M
Cost of Revenue $12.43M $12.51M $10.57M $10.95M $11.00M $11.90M $8.73M $9.48M
Gross Profit $94.80M $79.59M $72.55M $74.86M $63.38M $59.64M $51.39M $50.62M
Research & Development $11.06M $10.67M $8.78M $7.87M $7.48M $8.05M $7.75M $6.09M
Selling, General & Admin $64.11M $61.03M $53.14M $47.50M $46.46M $44.39M $44.02M $40.14M
Operating Income $16.92M $5.17M $7.92M $16.77M $6.73M $4.48M -$3.09M $1.68M
EBITDA $17.22M $5.50M $8.25M $17.11M $7.03M $4.81M -$2.77M $1.99M
Interest Income $827K $1.46M $1.20M $1.46M $1.16M $948K $1.18M $910K
Interest Expense $6.46M $6.95M $6.88M $7.15M $7.27M $7.36M $7.30M $7.70M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income $11.29M -$31.10M $2.23M $11.08M $621K -$1.93M -$9.22M -$5.11M
Basic EPS $0.06 -$0.18 $0.01 -- $0.00 -$0.01 -$0.06 --
Diluted EPS $0.06 -$0.18 $0.01 -- $0.00 -$0.01 -$0.06 --
Basic Shares Outstanding 180.9M 172.8M 170.5M -- 163.6M 159.5M 152.4M --
Diluted Shares Outstanding 189.9M 172.8M 177.6M -- 177.6M 159.5M 152.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $111.0M $71.62M $67.45M $122.0M $67.27M $37.60M
Short-Term Investments -- $0 $5.00M $0 $35.16M $96.19M
Cash & Short-Term Investments $111.0M $71.62M $72.45M $122.0M $102.4M $133.8M
Accounts Receivable, Net $51.05M $40.41M $39.20M $30.83M $17.46M $6.88M
Inventory $68.67M $48.17M $38.84M $24.73M $18.12M $8.35M
Total Current Assets $240.3M $167.7M $156.3M $186.8M $142.6M $152.2M
Property, Plant & Equipment, Net $4.95M $5.56M $5.97M $5.52M $6.63M $6.71M
Goodwill $22.86M $22.86M $22.86M $22.86M $22.86M $0
Intangible Assets $88.08M $98.92M $109.8M $120.6M $131.4M $0
Other Non-Current Assets $5.22M $5.41M $4.54M $4.73M $829K $232K
Total Non-Current Assets $143.2M $155.4M $166.3M $157.7M $161.8M $6.94M
Total Assets $383.5M $323.1M $322.6M $344.5M $304.4M $159.2M
Accounts Payable $3.08M $2.29M $11.56M $4.61M $8.92M $3.12M
Short-Term Debt $0 $15.10M $0 -- -- --
Other Current Liabilities $4.89M $1.09M $1.17M $2.66M $1.99M $322K
Total Current Liabilities $109.6M $100.4M $95.19M $73.62M $79.04M $28.21M
Long-Term Debt $220.3M $217.0M $190.9M $187.1M $88.07M $87.02M
Other Non-Current Liabilities $8.40M $1.97M $4.85M $31K $1.68M $3.53M
Total Non-Current Liabilities $260.3M $252.2M $234.2M $225.7M $130.1M $97.18M
Total Liabilities $369.8M $352.7M $329.4M $299.3M $209.1M $125.4M
Total Debt (incl. Leases) $258.1M $271.4M $229.2M $198.1M $88.07M $87.02M
Common Stock $17K $15K $14K $14K $13K $6.0K
Retained Earnings -$671.3M -$671.9M -$617.0M -$554.8M -$460.1M -$337.4M
Accumulated Other Comp. Income -$25K -$25K -$25K -$23K -$31K $6.0K
Total Stockholders' Equity $13.69M -$29.61M -$6.78M $45.19M $95.23M $33.76M
Total Equity $13.69M -$29.61M -$6.78M $45.19M $95.23M $33.76M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $131.1M $121.7M $111.8M $111.0M $91.60M $59.28M $58.44M $71.62M
Short-Term Investments -- -- -- -- -- -- -- $0
Cash & Short-Term Investments $131.1M $121.7M $111.8M $111.0M $91.60M $59.28M $58.44M $71.62M
Accounts Receivable, Net $68.60M $58.10M $56.30M $51.05M $53.75M $53.05M $46.33M $40.41M
Inventory $76.92M $80.93M $74.23M $68.67M $67.46M $67.28M $52.69M $48.17M
Total Current Assets $289.3M $274.8M $251.7M $240.3M $224.0M $185.6M $163.5M $167.7M
Property, Plant & Equipment, Net $4.64M $4.83M $5.03M $4.95M $4.95M $5.28M $5.26M $5.56M
Goodwill $22.86M $22.86M $22.86M $22.86M $22.86M $22.86M $22.86M $22.86M
Intangible Assets $79.95M $82.66M $85.37M $88.08M $90.79M $93.50M $96.21M $98.92M
Other Non-Current Assets $4.93M $5.03M $5.12M $5.22M $5.32M $5.06M $5.10M $5.41M
Total Non-Current Assets $134.0M $137.1M $140.3M $143.2M $146.2M $149.1M $152.0M $155.4M
Total Assets $423.2M $411.9M $392.0M $383.5M $370.2M $334.7M $315.5M $323.1M
Accounts Payable $8.04M $9.34M $11.47M $3.08M $6.53M $9.46M $6.35M $2.29M
Short-Term Debt -- $63.78M -- $0 $0 $0 $11.96M $15.10M
Other Current Liabilities $4.02M $4.98M $4.35M $4.89M $2.65M $1.63M $156K $1.09M
Total Current Liabilities $134.5M $189.6M $118.6M $109.6M $116.2M $95.17M $95.07M $100.4M
Long-Term Debt $189.7M $188.8M $221.2M $220.3M $219.5M $218.6M $217.8M $217.0M
Other Non-Current Liabilities $20.24M $12.72M $8.13M $8.40M $3.39M $7.75M $4.83M $1.97M
Total Non-Current Liabilities $240.0M $232.1M $260.4M $260.3M $254.9M $258.8M $255.5M $252.2M
Total Liabilities $374.4M $421.6M $379.0M $369.8M $371.1M $354.0M $350.6M $352.7M
Total Debt (incl. Leases) $226.1M $289.4M $258.6M $258.1M $257.7M $257.2M $268.8M $271.4M
Common Stock $19K $18K $18K $17K $17K $16K $16K $15K
Retained Earnings -$688.9M -$700.2M -$669.1M -$671.3M -$682.4M -$683.0M -$681.1M -$671.9M
Accumulated Other Comp. Income -$11K -$10K -$24K -$25K -$25K -$24K -$25K -$25K
Total Stockholders' Equity $48.78M -$9.73M $13.01M $13.69M -$861K -$19.30M -$35.13M -$29.61M
Total Equity $48.78M -$9.73M $13.01M $13.69M -$861K -$19.30M -$35.13M -$29.61M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $554K -$54.84M -$62.26M -$94.66M -$122.7M -$91.14M
Depreciation & Amortization $1.31M $1.23M $1.49M $1.40M $1.33M $1.47M
Stock-Based Compensation $22.37M $18.36M $10.72M $12.16M $11.38M $8.27M
Change in Receivables -$10.63M -$1.22M -$8.37M -$13.37M -$6.24M -$2.18M
Change in Inventory -$19.29M -$8.78M -$14.80M -$7.46M -$7.42M -$5.14M
Change in Payables -$69K -$9.61M $6.96M -$4.32M $5.53M -$2.49M
Operating Cash Flow $28.63M -$36.98M -$47.02M -$102.9M -$95.53M -$80.56M
Capital Expenditure -- -- -- -- -$1.08M -$377K
Free Cash Flow -- -- -- -- -$96.62M -$80.94M
Purchases of Investments $0 -$34.48M -$43.74M $0 -$43.02M -$101.8M
Sales & Maturities of Investments $0 $40.24M $40.00M $34.98M $103.6M $74.75M
Investing Cash Flow -$696K $4.88M -$6.00M $34.46M $97.96M -$27.41M
Common Stock Issued -- $0 $0 $30.00M $27.00M $65.89M
Financing Cash Flow $11.39M $36.17M -$1.61M $127.5M $27.25M $126.1M
Net Change in Cash $39.32M $4.07M -$54.64M $59.04M $29.67M $18.08M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $11.29M -$31.10M $2.23M $11.08M $621K -$1.93M -$9.22M -$5.11M
Depreciation & Amortization $300K $323K $337K $335K $300K $325K $315K $313K
Stock-Based Compensation $10.80M $11.07M $4.14M $5.27M $7.64M $5.01M $4.44M $3.60M
Change in Receivables -$10.49M -$1.81M -$5.25M $2.70M -$703K -$6.72M -$5.92M $723K
Change in Inventory $2.70M -$9.50M $851K -$4.01M -$4.08M -$7.57M -$3.62M -$3.14M
Change in Payables -$1.17M $286K $4.25M -$1.70M $2.00M -$4.43M $4.06M -$5.20M
Operating Cash Flow $35.47M $8.26M $9.87M $20.04M $18.43M $182K -$10.03M $1.98M
Purchases of Investments -- -- -- $0 $0 $0 $0 $0
Sales & Maturities of Investments -- -- -- $0 $0 $0 $0 $10.24M
Investing Cash Flow -$159K -$209K -$325K -$333K -$71K -$279K -$13K $10.02M
Financing Cash Flow -$25.98M $1.94M -$8.84M -$266K $13.85M $942K -$3.14M $398K
Net Change in Cash $9.34M $10.00M $708K $19.44M $32.21M $845K -$13.18M $12.39M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 85.4% 81.9% 82.5% 79.5% 73.1% 54.4%
Operating Margin 8.5% -16.6% -26.8% -74.3% -232.2% -408.8%
Net Profit Margin 0.2% -27.0% -38.0% -85.9% -247.5% -446.0%
Return on Equity (ROE) 4.0% -- -- -209.5% -128.9% -270.0%
Return on Assets (ROA) 0.1% -17.0% -19.3% -27.5% -40.3% -57.3%
Current Ratio 2.19x 1.67x 1.64x 2.54x 1.80x 5.40x
Quick Ratio 1.57x 1.19x 1.23x 2.20x 1.57x 5.10x
Debt to Equity 18.85x -- -- 4.38x 0.92x 2.58x
Revenue Growth (YoY) +43.7% +23.9% +48.7% +122.3% +142.7% --
Gross Profit Growth (YoY) +50.0% +22.9% +54.4% +141.5% +226.6% --
5Y Revenue / Share Growth +279.6% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 87.4% 86.6% 85.9% 85.4% 84.6% 82.2% 82.2% 81.9%
Operating Margin 12.7% 10.9% 11.4% 8.5% 3.7% -4.0% -10.1% -16.6%
Net Profit Margin -1.8% -5.1% 3.8% 0.2% -5.9% -13.0% -20.3% -27.0%
Return on Equity (ROE) -13.3% -- 92.3% 4.0% -- -- -- --
Return on Assets (ROA) -1.5% -4.2% 3.1% 0.1% -4.2% -9.6% -14.3% -17.0%
Current Ratio 2.15x 1.45x 2.12x 2.19x 1.93x 1.95x 1.72x 1.67x
Quick Ratio 1.58x 1.02x 1.50x 1.57x 1.35x 1.24x 1.17x 1.19x
Debt to Equity 4.63x -- 19.87x 18.85x -- -- -- --
Revenue Growth (YoY) +44.2% +28.7% +38.3% +42.8% +37.1% +48.8% +47.9% +35.4%
Gross Profit Growth (YoY) +49.6% +33.4% +41.2% +47.9% +55.8% +48.1% +48.2% +37.5%
Operating Income Growth (YoY) +151.4% +15.4% -- +899.0% -- -- -- --
Net Income Growth (YoY) +1718.0% -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) +92.4% +4440.1% -- +914.8% -- -- -- -73.6%
Source: SEC EDGAR CompanyFacts (CIK 0001867096) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:20 UTC · Open in terminal